Clinical Evaluation of Anti-CHIKV Hyperimmune Intravenous Immunoglobulins
NCT02230163
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Chikungunya Virus Infection
Interventions
BIOLOGICAL:
anti-CHIKV hyperimmune immunoglobulins
Sponsor
Centre Hospitalier Universitaire de la Guadeloupe